GlaxoSmithKline Consumer Nigeria Plc reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was NGN 3,141.64 million compared to NGN 5,614.31 million a year ago. Net income was NGN 108.36 million compared to NGN 134.19 million a year ago. Basic earnings per share from continuing operations was NGN 0.09 compared to NGN 0.11 a year ago.
For the nine months, sales was NGN 10,892.52 million compared to NGN 20,425.58 million a year ago. Net income was NGN 448.09 million compared to NGN 483.54 million a year ago. Basic earnings per share from continuing operations was NGN 0.37 compared to NGN 0.4 a year ago.